Fused azabicyclic compounds that inhibit vanilloid receptor subtype 1 (VR1) receptor

Compounds of formula (I), are novel VR1 antagonists that are useful in treating pain, inflammatory thermal hyperalgesia, urinary incontinence and bladder overactivity.

Saved in:
Bibliographic Details
Main Authors GOMTSYAN, ARTHUR R, WHITE, TAMMIE K, KOENIG, JOHN R, DRIZIN, IRENE, SCHMIDT, ROBERT G. JR, BAYBURT, EROL K, TURNER, SEAN C, ZHENG, GUO ZHU, PERNER, RICHARD J, DIDOMENICO, STANLEY JR, LEE, CHIH-HUNG
Format Patent
LanguageChinese
English
Published 01.08.2005
Online AccessGet full text

Cover

More Information
Summary:Compounds of formula (I), are novel VR1 antagonists that are useful in treating pain, inflammatory thermal hyperalgesia, urinary incontinence and bladder overactivity.
Bibliography:Application Number: TW20040123414